Advertisement
Advertisement

KRRO

KRRO logo

Korro Bio, Inc. Common Stock

13.12
USD
Sponsored
-0.65
-4.76%
Jun 25, 11:06 UTC -4
Open

Korro Bio, Inc. Common Stock Profile

About

Korro Bio Inc. is an RNA editing company focused on the discovery and development of a new class of precision genetic medicines for both rare and highly prevalent diseases. Korro Bio Inc., formerly known as Frequency Therapeutics Inc., is based in LEXINGTON, Mass.

Info & Links

CEO

Ram Aiyar

Headquarters

60 FIRST STREET, 2ND FLOOR, SUITE 250
CAMBRIDGE, MA 02141, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.korrobio.com

Auditor

Ernst & Young LLP

Share holders

104

Employees

58

Korro Bio, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

189.15M

Enterprise Value

127.46M

Enterprise Value/EBITDA(ttm)

-1.12

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

29.51

Price to Book(mrq)

2.39

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-1834.48%

Profit Margin(ttm)

-2053.10%

Return on Equity(ttm)

-115.95%

Return on Invested Capital(ttm)

-154.74%

Return on Assets(ttm)

-71.32%

Income Statement

Revenue(ttm)

3.84M

Revenue Per Share(ttm)

0.27

Gross Profit(ttm)

3.84M

EBITDA(ttm)3

-113.98M

Net Income Available to Common(ttm)

-113.50M

Diluted EPS(ttm)

-12.47

Share Statistics

Beta (5Y Monthly)

3.20

52-Week Change

3.35%

S&P 500 52-Week Change

21.44%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

14.42M

Dividend Yield

0.00%

Float4

13.76M

% Held by Insiders

4.60%

% Held by Institutions

13.18%

Balance Sheet

Total Cash(mrq)

113.97M

Total Cash Per Share(mrq)

7.90

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

6.90%

Quick Ratio(mrq)

6.90%

Book Value Per Share(mrq)

5.46

Cash Flow

Operating Cash Flow Per Share(ytd)

-8.36

Free Cash Flow(ytd)

-79.08M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement